Approval · Notice of Compliance 30691 · 2023
VITRECTO: Notice of Compliance 30691
Issued May 11, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30691
- Date
- May 11, 2023
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional Indication
Products in this notice
Medicinal ingredients
- MOXIDECTIN 5.6 MG per 0.4ML
- FLURALANER 112.5 MG per 0.4ML
- MOXIDECTIN 12.5 MG per 0.89ML
- FLURALANER 250 MG per 0.89ML
- MOXIDECTIN 25 MG per 1.79ML
- FLURALANER 500 MG per 1.79ML